Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

A Tender Notice
by NHS BLOOD & TRANSPLANT

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£102K
Sector
HEALTH
Published
19 Mar 2021
Delivery
01 Aug 2021 to 31 Jul 2023
Deadline
13 Apr 2021 17:00

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement of this procurement is for the supply of consumables and maintenance of the existing ART Universal machines. This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021.

CPV Codes

  • 33140000 - Medical consumables
  • 33693000 - Other therapeutic products
  • 50421000 - Repair and maintenance services of medical equipment

Indicators

  • Contract is suitable for SMEs.

Reference

Domains